Related Experiment Video

Updated: Nov 6, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.8K

mir-182-5p Regulates Cell Growth of Liver Cancer via Targeting RCAN1

Jianxing Zheng1, Dongyang Wu1, Libing Wang1

  • 1Department of Hepatobiliary Surgery, Tangshan Gongren Hospital, Tangshan, China.

Gastroenterology Research and Practice
|May 7, 2021
PubMed

Insights

Regulator of calcineurin 1 (RCAN1) suppresses liver cancer progression. MicroRNA-182-5p (miR-182-5p) promotes liver cancer by downregulating RCAN1, suggesting RCAN1 as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Regulator of calcineurin 1 (RCAN1) plays a role in various cancers, but its precise mechanism in liver cancer remains unclear.
  • Understanding RCAN1's function is crucial for developing novel liver cancer therapies.

Purpose of the Study:

  • To investigate the functional role and molecular mechanism of RCAN1 in liver cancer.
  • To explore the regulatory relationship between RCAN1 and miR-182-5p in liver cancer cells.

Main Methods:

  • Cell proliferation, migration, and invasion assays were performed.
  • Cell cycle progression was analyzed.
  • Expression levels of RCAN1 and miR-182-5p were quantified in liver cancer cells.

Main Results:

  • RCAN1 significantly suppressed liver cancer cell proliferation, migration, invasion, and cell cycle progression.
  • miR-182-5p was highly expressed in liver cancer cells and downregulated RCAN1 expression.
  • miR-182-5p promoted liver cancer cell growth by inhibiting RCAN1.

Conclusions:

  • RCAN1 acts as a tumor suppressor in liver cancer.
  • The miR-182-5p/RCAN1 axis is a key regulatory pathway in liver cancer progression.
  • RCAN1 represents a promising biomarker and therapeutic target for liver cancer diagnosis and treatment.

More Related Videos

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

673
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.6K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K